greg doucette bpc 157 BPC-157 & TB500 Healed Me… I’m Competing Again How to Mix BPC-157 |

A scoping review in Cureus (2025) added important context: dual-acting agonists like tirzepatide which targets both GLP-1 and GIP receptors produced greater reductions in weight and insulin sensitivity than GLP-1-only agents

Wolverine (BPC-157, TB-500) appears in research contexts involving multi-compound pathway research, formulation comparison, synergistic research models

Initially, the ML models were trained to identify molecules from each family, unlike the ligand-based and complex-based pharmacophore models, which were trained with the molecules exhibiting the highest activity by YN1 from each family

Multivariable logistic regression analyses and thematic synthesis were undertaken